SARTORIUS STEDIM BIOTECH EUR0.20 (POST SUBD) earnings per share and revenue

0RG8 earnings per share for the last quarter are 0.76 EUR whereas the estimation was 0.80 EUR which accounts for -4.68% surprise. Company revenue for the same period amounts to 655.40 M EUR despite the estimated figure of 685.76 M EUR. Estimated earnings per share for the next quarter are 0.97 EUR, and revenue is expected to reach 710.61 M EUR. Also watch annual changes over time to get a bigger picture of 0RG8 earnings per share and revenue dynamics.